Method of using matrix metalloproteinase inhibitors in filtering blebs following glaucoma filtering surgery and in the treatment of ischemic damage to the retina and optic nerve
US6503892B2 · kind B2 · utility
3Cited by
1References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2001 |
| Grant date | Jan 7, 2003 |
| Priority date | — |
| Expiry date | Apr 25, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method of inhibiting, preventing, and/or treating conjunctival filtering bleb leaks that may occur following glaucoma filtering surgery by administering Matrix Metalloproteinase inhibitors to glaucoma patients who have undergone such surgery. The invention additionally includes a method of using Matrix Metalloproteinase inhibitors to inhibit, prevent, and/or treat ischemic damage to the retina and optic nerve in patients in need of such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.